24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
A crossover, randomized, single-masked study which compares the short-term (3 months) 24-hour
IOP control and safety of travoprost/timolol fixed combination given once in the evening,
versus that of latanoprost/timolol fixed combination given once in the evening in patients
with exfoliative glaucoma. The primary objective of this trial is to compare the quality of
24-hour IOP control after 3 months of chronic therapy with these two medications.